May 17-18, 2017 — Chicago, IL

Event:                 MedCity INVEST            

Panel Session:   Beyond the Pill and Product, Whither Now?

With the question of value looming, more and more companies are starting to focus on the importance of not only the drug or the device but the services that must be wrapped around the product to demonstrate both clinical value for patients and economic value for health systems. How has that changed perspectives of potential acquirers, VCs, as well as hospitals looking to do pilots?


  • Joseph Johnson, Managing Director, L.E.K. Consulting


  • Jon Handler, M.D., Vice President of Digital Innovation, Baxter Healthcare Corporation
  • Renee Compton Ryan, Vice President, Venture Investments, Johnson & Johnson Innovation
  • Dirk Schapeler, VP Digital Innovation US, Bayer       
  • Lisa Shafer, Sr Director New Devices and Bioelectronic Technologies, Teva Pharmaceuticals

Date/Location:   Wednesday May 17, 2017 
                         Four Seasons Hotel
                         Chicago, IL

Time:                10:30 a.m. — 11:15 a.m.        

About Joseph Johnson   

Joe Johnson is a Managing Director and Partner, as well as the head of L.E.K. Consulting’s New York office. He is one of the leaders in L.E.K.’s Healthcare Services practice and plays an instrumental role in helping senior executives across the industry develop and implement new strategies to address sweeping federal healthcare reforms that are having a significant impact in this market. He has more than 15 years of consulting experience managing and directing client engagements and has worked on a substantial number of strategic growth, operations and commercial due diligence projects across the healthcare services industry. His expertise in the Healthcare Services practice includes areas such as quality, healthcare IT, Medicare, Medicaid and provision of healthcare services, among others.

About MedCity INVEST

MedCity INVEST is the premier national healthcare investing conference based in the Midwest. For well over a decade, this conference has united active investors with corporate business development executives to syndicate investment opportunities with promising start-ups from the biopharmaceutical, diagnostics, medical devices, digital health/health IT, and health services sectors. Join us at the Four Seasons Chicago May 17-18, 2017 to hear from innovative investors, prominent industry players and 40+ startup companies—highlighting opportunities to invest in the most elite companies offering innovative approaches or trying to solve some of healthcare’s greatest challenges.

About L.E.K. Consulting

L.E.K. Consulting is a global management consulting firm that uses deep industry expertise and rigorous analysis to help business leaders achieve practical results with real impact. We are uncompromising in our approach to helping clients consistently make better decisions, deliver improved business performance and create greater shareholder returns. The firm advises and supports global companies that are leaders in their industries — including the largest private and public sector organizations, private equity firms and emerging entrepreneurial businesses. Founded more than 30 years ago, L.E.K. employs more than 1,200 professionals across the Americas, Asia-Pacific and Europe. For more information, go to